Tags Biotechnology

Tag: Biotechnology

BioBuilder Educational Foundation and K2 Scientific Bring Synthetic Biology Programs and Lab Equipment to High-Need High Schools

eNewsChannels NEWS: -- As a world-recognized program that trains the next generation of innovators and skilled workers in synthetic biology, the BioBuilder Educational Foundation announced new work with K2 Scientific to make high quality tools and equipment for life science research widely accessible. BioBuilder has partnered with K2 Scientific, who will donate industry-grade refrigeration units to four high-need high schools participating in the BioBuilderClub this academic year.

Dosaggio by SottoPelle Partners with with PatientNow electronic health records

eNewsChannels NEWS: -- Dosaggio™ by SottoPelle® and PatientNow announced today that they have entered into a partnership that integrates the two companies' innovative technologies, to improve efficiencies and elevate patient care for providers offering bioidentical hormone replacement therapy (BHRT).

Dosaggio by SottoPelle Partners with Cerbo to improve efficiencies and elevate patient care for providers

eNewsChannels NEWS: -- Dosaggio™ by SottoPelle® and Cerbo announced today that they have entered into a partnership that integrates the two companies' innovative technologies, to improve efficiencies and elevate patient care for providers offering bioidentical hormone replacement therapy (BHRT).

With two-year grant awarded by BioMADE, the BioBuilder Educational Foundation will expand program that has supported thousands of high school inventors

eNewsChannels NEWS: -- Thanks to a two-year grant recently awarded by BioMADE, the BioBuilder Educational Foundation will expand a program that has supported thousands of high school inventors over the last decade. BioBuilder is leading the project, "Launching High School Bioengineers on their Paths to College and Careers," with funding that will bring the authentic tools and approaches for engineering biology to BioBuilderClub students nationwide in collaboration with East Tennessee State University, Ars Biotechnica, and Daicel Arbor Biosciences.

Kalyagen Announces Speaking Engagement at 8th Annual Biohacking Conference in Beverly Hills

eNewsChannels NEWS: -- Kalyagen is pleased to announce that it will be attending and its founder, Christian Drapeau, will be speaking at the upcoming 8th Annual Biohacking Conference. The conference, which is completely sold out, will be held September 15-17 at The Beverly Hilton in Beverly Hills, California.

Proteios Technology Awarded $1.6M NIH SBIR Grant to Commercialize its Multivariate Cell Isolation Technology

eNewsChannels NEWS: -- Proteios Technology, Inc. is pleased to announce it's received a $1.6 million SBIR Phase II grant from the National Institutes of Health (NIH) to commercialize its multivariate (parallel) cell isolation technology. Grant funds will be used to extend Proteios' cell isolation kits to include up to 20 of the most common cell types currently used in cell therapy development.

Kalyagen Announces Attendance at the Fort Lauderdale Open 2022 with Golf Professional Jerrel Gill

eNewsChannels NEWS: -- Kalyagen® is pleased to announce that it will be attending the Fort Lauderdale Open as part of its sponsorship of golf professional Jerrel Gill. The Open will be hosted at the Fort Lauderdale Country Club on May 2-3, 2022.

Paleo f(x) 2022 Conference in Austin: Kalyagen attending and hosting a booth #121

eNewsChannels NEWS: -- Kalyagen is pleased to announce that it will be attending and hosting a booth (#121) at the upcoming Paleo f(x)™ 2022 conference to be held in Austin on April 29 - May 1. STEMREGEN® is a unique and patent-pending blend of proprietary plant-based extracts documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Vyriad, Inc. says Oral Vaccine Boosts COVID Immunity: study conducted on nonhuman primates published in the journal Vaccine

eNewsChannels NEWS: -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2. The full study conducted on nonhuman primates is published in the journal Vaccine.

Pure MHC LLC and Myrio Announce Collaboration to Research and Develop Targeted Antibody-Based Cancer Therapies

eNewsChannels NEWS: -- Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC's proprietary offering of MHC peptide targets for oncology with Myrio's revolutionary Retained Display(tm) (ReD) antibody discovery process to initially create up to three novel therapies based on targets distinct to tumors across multiple types of cancer.

WHAT'S NEWS